Results 121 to 130 of about 13,148 (179)

Relapsing or refractory idiopathic thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the role of rituximab. [PDF]

, 2010
Ahmad, Allford, Amorosi, Arici, Arnold, Bell, Bianchi, Caramazza, Cataland, Chemnitz, Chow, Cines, Clark, Daraibi, Elkins, Elliott, Fankouri, Furlan, Garvey, George, Gutterman, Hayward, Heidel, Jasti, Kameda, Kappers-Klunne, Koulova, Lalmuanpuii, Lankford, Lara, Ling, Lämmle, Mannucci, McDonald, McMinn, Millward, Moake, Moore, Mori, Niewold, Patino, Pereira, Quintini, Raife, Raife, Reddy, Rick, Rizvi, Rock, Rock, Ruiz, Rüfer, Sadler, Sadler, Sallah, Scaramucci, Scott, Scully, Thompson, Tsai, Tsai, Tsai, Vesely, Veyradier, Yassa, Yomtovian   +65 more
core   +1 more source

Incidence of thrombotic microangiopathies in Quebec: insight from a laboratory centralizing ADAMTS-13 testing. [PDF]

Orphanet J Rare Dis, 2022
Merlen C, Pépin E, Barry O, Cormier A, Dubois C, Lapeyraque AL, Troyanov S, Rivard GE, Bonnefoy A.   +8 more
europepmc   +1 more source

ADAMTS13 deficiency with elevated levels of ultra-large and active von Willebrand factor in P. falciparum and P. vivax malaria. [PDF]

A deficiency in ADAMTS13 (a von Willebrand factor [VWF] cleaving protease) is associated with accumulation of prothrombogenic unusually large VWF multimers (UL-VWF) in plasma. We studied VWF release and proteolysis in patients with symptomatic Plasmodium
Syafruddin D
core  

PO20 | DYSFUNCTION OF THE ADAMTS-13 / VON WILLEBRAND FACTOR AXIS, MEDIATED BY NETOSIS, AS A DRIVER OF PROTHROMBOTIC STATE AND UNFAVORABLE PROGNOSIS IN ONCOGYNECOLOGICAL PATIENTS

Bleeding, Thrombosis and Vascular Biology
Introduction. An imbalance between von Willebrand factor (VWF) and its primary protease, ADAMTS-13, plays a crucial role in the pathogenesis of microthrombosis and endotheliopathy.
Alexander Makatsariya
doaj  

Sustained VWF-ADAMTS-13 axis imbalance and endotheliopathy in long COVID syndrome is related to immune dysfunction. [PDF]

J Thromb Haemost, 2022
Fogarty H, Ward SE, Townsend L, Karampini E, Elliott S, Conlon N, Dunne J, Kiersey R, Naughton A, Gardiner M, Byrne M, Bergin C, O'Sullivan JM, Martin-Loeches I, Nadarajan P, Bannan C, Mallon PW, Curley GF, Preston RJS, Rehill AM, Baker RI, Cheallaigh CN, O'Donnell JS, Irish COVID-19 Vasculopathy Study (iCVS) Investigators.   +23 more
europepmc   +1 more source

Low ADAMTS-13/VWF ratio and altered gut-liver axis predict complications of advanced chronic liver disease: a pilot study. [PDF]

Gastroenterol Rep (Oxf), 2022
Ponziani FR, Sacco M, Tardugno M, Santopaolo F, Marsico A, Manna S, Lancellotti S, Gasbarrini A, De Cristofaro R, Pompili M.   +9 more
europepmc   +1 more source

Reversible posterior leukoencephalopathy syndrome in a patient with thrombotic thrombocytopenic purpura [PDF]

, 2011
Aridon, P., D'Amelio, M., LO RE, M., Mazzola, M., Quintini, G., Ragonese, P., Savettieri, G., Talamanca, S., Terruso, V.   +8 more
core   +1 more source

Congenital ADAMTS-13 deficiency presenting as life-threatening thrombosis during pregnancy. [PDF]

BMJ Case Rep, 2021
Hasan F, Gupta A, Chandra D, Nityanand S.   +3 more
europepmc   +1 more source

Dynamic Monitoring of ADAMTS-13 Activity for Differential Diagnosis Across the Spectrum of Sepsis-Associated Thrombotic Microangiopathies. [PDF]

Mediterr J Hematol Infect Dis
Liu Y, Lu F, Ji B, Song W, Shen H, Xu Y, Yang B.   +6 more
europepmc   +1 more source

ADAMTS-13-regulated nuclear factor E2-related factor 2 signaling inhibits ferroptosis to ameliorate cisplatin-induced acute kidney injuy. [PDF]

Bioengineered, 2021
Meng X, Huang W, Mo W, Shu T, Yang H, Ning H.   +5 more
europepmc   +1 more source